Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma

Project Details


Project Narrative Glioblastoma (GBM) is one of the most devastating human cancers that almost always recurs due to the presence of invasive therapy-resistant infiltrating cancer cells at the tumor margin. Magnetic hyperthermia therapy (MHT) is a powerful, nanotechnology-based treatment that may enhance the effects of radiation therapy (RT) and chemotherapy against infiltrating GBM tumors.
Effective start/end date1/12/1930/11/22


  • National Cancer Institute: $653,976.00
  • National Cancer Institute: $706,027.00
  • National Cancer Institute: $619,800.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.